$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
Osimertinib latest version of instructions for use | latest price
2025-10-19 11:44:20
Check Details
What is the current price of afatinib? Will the price of the anti-cancer drug afatinib be reduced in 2021?
2025-10-19 11:44:20
Check Details
[Advantages] Osimertinib is known as a lung cancer targeted drug with high efficiency, low toxicity and outstanding efficacy
2025-10-19 11:44:20
Check Details
What is the latest price of afatinib in May 2021? Where can I buy regular afatinib in China?
2025-10-19 11:44:20
Check Details
Which country does imported afatinib come from? How many manufacturers are there for afatinib?
2025-10-19 11:44:20
Check Details
【What you are looking for】Afatinib|Gitari|afatinib drug instructions
2025-10-19 11:44:20
Check Details
What are the advantages of alectinib in treating lung cancer? Which aletinib, zotinib, is better for treating lung cancer?
2025-10-19 11:44:20
Check Details
[Alectinib Drug Encyclopedia] The latest translation of the Chinese description of Alectinib
2025-10-19 11:44:20
Check Details
Where can I buy Alectinib online?
2025-10-19 11:44:20
Check Details
[Latest Medical Insurance Policy for Aletinib] How much will Aletinib be reimbursed by medical insurance in 2021?
2025-10-19 11:44:20
Check Details
What versions of lorlatinib are currently available? How much will each version of Lorlatinib cost in 2021?
2025-10-19 11:44:20
Check Details
After osimertinib resistance, can dacomitinib be used to treat it?
2025-10-19 11:44:20
Check Details
1
2
...
3938
3939
3940
3941
3942
3943
3944
...
4163
4164
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Weight Gain and Edema Management, Monitoring of Repotrectinib (Augtyro) During Treatment
2
How to Take Tucatinib (Tukysa): Dosing Schedule, Combination Use & Missed Dose Guidance
3
Anamorelin (ADLUMIZ): GHS-R1a Agonist for Cancer Cachexia—Mechanism, Use, and Safety Boundaries
4
Vemurafenib Mechanism and Clinical Indications: BRAF V600E Mutant Melanoma and ECD Treatment
5
Ribociclib: Mechanism of Action and Approved Uses in Breast Cancer
6
Binimetinib + Encorafenib: Dual MEK/BRAF Targeting in BRAF+ Tumors
7
Neratinib Dosing: 240mg Start, Diarrhea Prophylaxis, Hepatic Adjustment
8
Selumetinib and KRAS Mutations: Where the MEK Inhibitor Actually Fits
9
Erdafitinib in Lung Squamous Cell Carcinoma: Indication Boundaries and FGFR Interpretation
10
Daraxonrasib (Rasonque): Chemical Identity and RAS Tri-Complex Mechanism
11
Tamoxifen and Feeling Older: Managing Hot Flashes, Fatigue, and Skin Changes
12
FDA Approves Pembrolizumab for TMB-H Solid Tumors: Threshold ≥13 mut/Mb, KEYNOTE-158 Data